Clarke B. Futch Chairman and Chief Executive Officer

Clarke B. Futch is Chairman and Chief Executive Officer of HCRx.  Mr. Futch is responsible for all of HCRx’s business activities, sets the strategic direction of the firm and remains actively involved in new opportunities. He is considered an early pioneer in the royalty space, having been named in 2010 one of the future leaders in biotech finance by BioWorld, a leading industry publication. Since 2001, he has led/co-led 60+ royalty-related acquisitions with an aggregate value of nearly $4 billion. Mr. Futch brings over 30 years of experience in biopharmaceutical/healthcare investing and financing, having raised over $8 billion in equity and debt principal capital across eleven vehicles and executed more than 165 transactions, including royalty, equity, debt and M&A financings. Before co-founding HCRx, Mr. Futch served as a partner at Paul Capital Partners where he co-managed the firm’s royalty activities as a member of the royalty management committee. Previously, he served as a founding member of the healthcare group at Thomas Weisel Partners (now Stifel), and as a vice president at Raymond James. Mr. Futch currently serves as Chairman of the Board of Managers of HCRx Holdings as well as Chairman of the Board of Directors of Valinor Pharmaceuticals. Mr. Futch holds a B.A., magna cum laude, from Vanderbilt University and a J.D. from the University of Virginia School of Law.